262 related articles for article (PubMed ID: 18780571)
41. Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy.
Breccia M; Lo-Coco F
Expert Opin Biol Ther; 2011 Feb; 11(2):225-34. PubMed ID: 21142804
[TBL] [Abstract][Full Text] [Related]
42. Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience.
Zhang L; Zhao H; Zhu X; Chen Y; Zou Y; Chen X
Pediatr Blood Cancer; 2008 Aug; 51(2):210-5. PubMed ID: 18428427
[TBL] [Abstract][Full Text] [Related]
43. Effect of dialysis on all trans retinoic acid levels in a child with acute promyelocytic leukemia and renal failure.
Rajpurkar M; Alcasabas P; Warrier I; Valentini RP; Fassinger N; Frattarelli DA; Ravindranath Y
Pediatr Blood Cancer; 2007 Dec; 49(7):994-6. PubMed ID: 16609947
[TBL] [Abstract][Full Text] [Related]
44. Haemostatic problems in acute promyelocytic leukaemia.
Arbuthnot C; Wilde JT
Blood Rev; 2006 Nov; 20(6):289-97. PubMed ID: 16757074
[TBL] [Abstract][Full Text] [Related]
45. Novel strategies in treatment of acute promyelocytic leukemia.
Lo-Coco F; Cicconi L
Leuk Suppl; 2012 Aug; 1(Suppl 2):S18-9. PubMed ID: 27175235
[TBL] [Abstract][Full Text] [Related]
46. The thrombophilic state in acute promyelocytic leukemia.
Tallman MS
Semin Thromb Hemost; 1999; 25(2):209-15. PubMed ID: 10357088
[TBL] [Abstract][Full Text] [Related]
47. Acute promyelocytic leukemia: an overview with implications for oncology nurses.
Walker DK; Held-Warmkessel J
Clin J Oncol Nurs; 2010 Dec; 14(6):747-59. PubMed ID: 21112852
[TBL] [Abstract][Full Text] [Related]
48. A comprehensive review of acute promyelocytic leukemia in children.
Mantadakis E; Samonis G; Kalmanti M
Acta Haematol; 2008; 119(2):73-82. PubMed ID: 18285695
[TBL] [Abstract][Full Text] [Related]
49. APL and differentiation therapy--joint international congress.
Zelent A
IDrugs; 2001 Nov; 4(11):1257-62. PubMed ID: 15942830
[TBL] [Abstract][Full Text] [Related]
50. The unique hemostatic dysfunction in acute promyelocytic leukemia.
Kwaan HC
Semin Thromb Hemost; 2014 Apr; 40(3):332-6. PubMed ID: 24590422
[TBL] [Abstract][Full Text] [Related]
51. Blood Parameters in Treatment with Arsenic Trioxide in Acute Promyelocytic Leukemia:
Mohammadi Kanesbi M; Jarahi L; Keramati MR
Int J Hematol Oncol Stem Cell Res; 2020 Apr; 14(2):130-139. PubMed ID: 32461798
[TBL] [Abstract][Full Text] [Related]
52. Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia.
Kulkarni U; Mathews V
Front Oncol; 2021; 11():621566. PubMed ID: 33718181
[TBL] [Abstract][Full Text] [Related]
53. Acute renal failure during ATRA treatment.
Yarali N; Tavil B; Kara A; Ozkasap S; Tunç B
Pediatr Hematol Oncol; 2008 Mar; 25(2):115-8. PubMed ID: 18363177
[TBL] [Abstract][Full Text] [Related]
54. Toward Candidate Proteomic Biomarkers in Clinical Monitoring of Acute Promyelocytic Leukemia Treatment with Arsenic Trioxide.
Cao F; Li X; Yang Y; Fang H; Qu H; Chang N; Ma Q; Cao W; Zhou J; Wang W
OMICS; 2019 Feb; 23(2):119-130. PubMed ID: 30767729
[TBL] [Abstract][Full Text] [Related]
55. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
[TBL] [Abstract][Full Text] [Related]
56. [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
Hisatake J; Shimozuma J
Rinsho Ketsueki; 2008 Jun; 49(6):408-12. PubMed ID: 18646608
[TBL] [Abstract][Full Text] [Related]
57. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.
Jácomo RH; Melo RA; Souto FR; de Mattos ER; de Oliveira CT; Fagundes EM; Bittencourt HN; Bittencourt RI; Bortolheiro TC; Paton EJ; Bendlin R; Ismael S; Chauffaille Mde L; Silva D; Pagnano KB; Ribeiro R; Rego EM
Haematologica; 2007 Oct; 92(10):1431-2. PubMed ID: 18024380
[TBL] [Abstract][Full Text] [Related]
58. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
[TBL] [Abstract][Full Text] [Related]
59. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
60. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
